News Chart Cannara Biotech Inc.

Equities

LOVE

CA13765U2002

Delayed Toronto S.E. Other stock markets 18:49:24 17/06/2024 BST			5-day change	1st Jan Change
0.71 ^CAD	-1.39%		0.00%	-14.46%

04-29	Cannara Biotech Turns Negative As Reports Wider Q2 Net Loss Vs a Year Ago, Despite Revenue up 51%	MT
04-29	Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.	CI

1a4999f0bebf7f053ce56ac97bbf1c.XSMiF5AuZfTYgdaQMcl82EJb9Tbb-2HX1itZi7jNWL8.MxdyQ9p2ErabxofGcoQPkS4tpnDjnC6FgkwQ09C-LYhlfFtu20crvrrLoQ~ded1055553ba71f36777c6757e585b9a